Royalty Pharma plc (FRA:RPD)

Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	631.91	929.03	477.01	1,711	1,541	1,009
Short-Term Investments	13.2	58.2	18.3	25.72	647.87	1,053
Cash & Short-Term Investments	645.11	987.23	495.31	1,736	2,189	2,062
Cash Growth	-64.22%	99.31%	-71.48%	-20.67%	6.16%	505.29%
Accounts Receivable	870.68	810.73	760.84	727.92	682.66	626.36
Receivables	870.68	810.73	760.84	727.92	682.66	626.36
Other Current Assets	4.45	4.19	18.04	90.52	6.63	8.6
Total Current Assets	1,520	1,802	1,274	2,555	2,878	2,697
Long-Term Investments	658.34	1,260	1,012	735.82	909.59	916.64
Other Intangible Assets	5.32	5.32	1.78	14.5	5.67	28.67
Long-Term Accounts Receivable	15,134	15,127	14,089	13,493	13,718	12,368
Other Long-Term Assets	59.57	28.21	4.74	15.13	4.14	10
Total Assets	18,323	18,223	16,382	16,813	17,516	16,020
Accounts Payable	20.21	13.37	15.17	7.91	5.62	10.78
Accrued Expenses	85.61	98.06	51.68	54.16	57.7	60.75
Current Portion of Long-Term Debt	999.44	997.77	-	997.51	-	-
Other Current Liabilities	98.2	144.41	94.53	107.2	107.93	236.37
Total Current Liabilities	1,207	1,254	161.38	1,167	171.25	307.89
Long-Term Debt	7,003	6,615	6,135	6,119	7,096	5,817
Other Long-Term Liabilities	592.77	12.08	0.9	2.5	-	-
Total Liabilities	8,820	7,880	6,298	7,288	7,267	6,124
Common Stock	0.11	0.11	0.11	0.11	0.11	0.1
Additional Paid-In Capital	4,128	4,103	4,011	3,666	3,508	2,866
Retained Earnings	2,223	2,846	2,518	1,965	2,255	1,921
Treasury Stock	-2.61	-2.66	-2.63	-2.81	-2.72	-2.32
Comprehensive Income & Other	-	-	-	-	16.49	34.4
Total Common Equity	6,348	6,947	6,526	5,628	5,777	4,819
Minority Interest	3,155	3,396	3,558	3,897	4,472	5,077
Shareholders' Equity	9,503	10,342	10,084	9,525	10,249	9,896
Total Liabilities & Equity	18,323	18,223	16,382	16,813	17,516	16,020
Total Debt	8,023	7,612	6,135	7,116	7,096	5,817
Net Cash (Debt)	-7,378	-6,625	-5,640	-5,380	-4,907	-3,755
Net Cash Per Share	-12.71	-11.15	-9.35	-12.28	-11.83	-10.00
Filing Date Shares Outstanding	432.29	433.32	446.69	443.17	432.96	388.13
Total Common Shares Outstanding	432.29	445.99	446.69	443.17	432.96	388.14
Working Capital	313.72	548.52	1,113	1,388	2,707	2,389
Book Value Per Share	14.68	15.58	14.61	12.70	13.34	12.42
Tangible Book Value	5,418	6,941	6,525	5,614	5,771	4,790
Tangible Book Value Per Share	12.53	15.56	14.61	12.67	13.33	12.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.